“Counterpart” means a counterpart to this Agreement entered into by a Subsidiary of a Borrower pursuant to Section 20 hereof, substantially in the form of Exhibit V annexed hereto.
“Credit Agreement” has the meaning set forth in the Preliminary Statements of this Agreement.
“Intellectual Property” means
(a) Copyrights, Copyright Registrations and Copyright Rights;
(b) Patents and Issued Patents;
(c) Trademarks, Trademark Registrations, the Trademark Rights and the goodwill of the applicable Grantor’s business connected with the use of and symbolized by the foregoing;
(d) all trade secrets, trade secret rights, know-how, customer lists, processes of production, ideas, confidential business information, techniques, processes, formulas, and all other proprietary information; software, source code and object code and all other intellectual property and similar proprietary rights, including: the right to sue or otherwise recover for any past, present and future infringement, dilution, misappropriation, or other violation or impairment of any of the foregoing;
(e) all license fees, royalties, income, payments, claims, damages and proceeds of suit, now or hereafter due and/or payable with respect to any of the foregoing and all agreements relating to the license, ownership, development, use or disclosure of any of the foregoing; and
(f) all Proceeds of any of the foregoing.
“Intellectual Property Collateral” means, with respect to any Grantor, all right, title and interest (including rights acquired pursuant to a license or otherwise) in and to all Collateral consisting of Intellectual Property.
“IP Filing Office” means the U.S. Patent and Trademark Office and the U.S. Copyright Office (or any successor office), as applicable.
“IP Security Agreement” means a Trademark Security Agreement, substantially in the form of Exhibit I annexed hereto, and a Patent Security Agreement, substantially in the form of Exhibit II annexed hereto, and a Copyright Security Agreement, substantially in the form of Exhibit III annexed hereto, as applicable.
“IP Supplement” means an IP Supplement, substantially in the form of Exhibit IV annexed hereto.
“Issued Patents” means all Patents that have been or may hereafter be issued or applied for thereon in the United States and any state thereof (including, without limitation, the patents and patent applications set forth on Schedule 7 annexed hereto, as the same may be amended pursuant hereto from time to time).
23